Cho YS, et al. - In candidates with mild, moderate, and moderately severe hearing impairment, researchers assessed the clinical effectiveness of a personal sound amplification product (PSAP) by comparing its performance with that of basic hearing aid (HA) and a premium HA. No differences were found between PSAP, basic HA, and premium HA for speech perception, sound quality, listening effort, and user preference in this prospective, single-institution cohort study involving 56 adults (mean age was 56 years). However, the premium HA had better performance over most tests for the group with moderately severe hearing loss, and 70% of these respondents preferred to use the premium HA. In patients with mild to moderate hearing impairment, basic and premium HAs were not superior to PSAPs, suggesting that PSAPs could be used as an option to HAs in these patient populations. However, if hearing loss is more severe, then HAs should be considered as an option to manage hearing loss, particularly premium HAs.